Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02953977 · ClinicalTrials.gov registry record · NA
Strong Men, Strong Communities Diabetes Risk Reduction in American Indian Men
A NA study, sponsored by Washington State University.
- Completed
- Registry status
- NA
- Development phase
- 257
- Enrollment target
NCT02953977: Completed NA study, sponsored by Washington State University.
NCT02953977 is a NA study that has completed, run by Washington State University. The registered enrollment target is 257 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02953977, a NA study, has completed, sponsored by Washington State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 257 participants
- Enrollment target
Study Summary
SMSC will inform the design and implementation of culturally informed, community-based lifestyle interventions for diabetes prevention in AI men in our partner communities and elsewhere, as well as in men of other minority groups who experience a heavy burden of diabetes.
Primary Outcome
7.5% weight loss from baseline weight
Interventions
- BEHAVIORAL Diabetes Prevention Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2018-06-15 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
What the finished NCT02953977 record still lists
NCT02953977 is an interventional study that assigns participants to a tested intervention. The registered 257 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 1 intervention - of which Diabetes Prevention Program is the first listed.
NCT02953977 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02953977 about?
NCT02953977 is a clinical study titled "Strong Men, Strong Communities Diabetes Risk Reduction in American Indian Men". SMSC will inform the design and implementation of culturally informed, community-based lifestyle interventions for diabetes prevention in AI men in our partner communities and elsewhere, as well as in men of other minority groups who experience a heavy burden of diabetes.
What is the current status of trial NCT02953977?
This trial is currently completed. It is a NA study. The enrollment target is 257 participants. The study started on 2018-06-15. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT02953977?
The interventions under investigation include: Diabetes Prevention Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02953977?
This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02953977's enrollment target sits among peer trials
257 403rd of 2000 higher than 1,597 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03618550 · 257 participants · Phase 2
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
- NCT04674267 · 257 participants · NA
Resilience and Equity in Aging, Cancer, and Health (REACH)
- NCT06099288 · 257 participants · NA
Strong Families Start at Home/Familias Fuertes Comienzan en Casa
- NCT06207084 · 257 participants · NA
The Fit With Us Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI